Efficacy News and Research

RSS
FDA accepts NPS Pharmaceuticals' Natpara BLA for review

FDA accepts NPS Pharmaceuticals' Natpara BLA for review

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

Memorial Sloan-Kettering to use Sutro's cell-free protein synthesis technology to produce bispecific antibodies

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Portage acquires approximately 54% equity in Biohaven

Portage acquires approximately 54% equity in Biohaven

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Study explores safety and efficacy of scoop and run approach in Philadelphia

Study explores safety and efficacy of scoop and run approach in Philadelphia

Study shows link between nurse fatigue and clinical decision regret

Study shows link between nurse fatigue and clinical decision regret

Cerenis' Phase IIb CHI-SQUARE study fails to meet primary endpoint in post-ACS patients

Cerenis' Phase IIb CHI-SQUARE study fails to meet primary endpoint in post-ACS patients

Research confirms superior antitumor activity of novel anticancer agent FL118

Research confirms superior antitumor activity of novel anticancer agent FL118

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Kessler Foundation to conduct pilot study on improving memory, function in MS patients

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

Researchers develop a class of compounds that may help eradicate Chagas disease

Researchers develop a class of compounds that may help eradicate Chagas disease

Fluidigm announces universal sample prep workflow for single-cell DNA sequencing

Fluidigm announces universal sample prep workflow for single-cell DNA sequencing

Genotyping strategy could boost celiac screening efficacy

Genotyping strategy could boost celiac screening efficacy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.